Scope of Parkinson’s in the United States


According to the Parkinson’s Foundation, over one million Americans live with Parkinson’s Disease, with men being 1.5 times more likely to receive a diagnosis than women. 60,000 Americans are given a diagnosis of Parkinson’s Disease each year, and it has found a place in the mainstream due to celebrities Michael J. Fox raising awareness for the disease. It is a disease that usually shows up later in life, with a small portion of people getting diagnosed before age 50.

The therapies required for Parkinson’s Disease can cost up to $100,000 per person, per year with medications having a costly price tag for those who want to find relief from the symptoms of the disease.

Understanding Parkinson’s Disease

Parkinson’s Disease is a neurogenerative disorder that affects the way your brain’s neurons produce dopamine. The disorder usually affects the way your brain and your nerves interact with each other to cause movement. Those with Parkinson’s can experience physical or motor-symptoms that include tremors, slowness in moving, difficulty walking, rigid limbs, and problems with balance.

Some with Parkinson’s also may experience non-motor symptoms of the disease as well, and may demonstrate signs of apathy or can struggle with depression, behavior disorders or cognitive impairments. It’s important to note that many patients differ on how the Parkinson’s presents itself.

As of now, there has not been an effective treatment that has been found to reverse the symptoms of the disease, but rather control it. Many pharmaceutical drugs prescribed to Parkinson’s patients are focused on increasing the dopamine in the brain. There are also two surgeries that are common for more serious Parkinson’s patients to explore.

Lately, however, the entire Parkinson’s community has been abuzz about the possibility for medical marijuana to treat the symptoms of Parkinson’s Disease.

Medical Marijuana and Parkinson’s

Parkinson’s is still a disease that researchers are looking to understand, but many have come out in support of how CBD (cannabidiol) specifically interacts with the brain in certain neurogenerative disorders providing cell regeneration.

Science communities are getting excited about the prospect of cannabis to eliminate the neurotoxins in the brain that are associated with Parkinson’s Disease and are finding cannabis as a promising preventative treatment.

CBD is showing promise in its ability to prevent brain cell death and contribute to neurogenesis, the process of repairing the cells of the brain that have been damaged, which can help those suffering from Parkinson’s experience a lessening of their symptoms. Others embrace the power of CBD to prevent neurodegeneration, preserving the brain’s functions.

Cannabis has been lauded across the board for its potential to aid in mental health treatment, particularly with depression and anxiety, showing that there is a significant place for medical marijuana to aid in the treatment of the non-motor symptoms of Parkinson’s Disease. CBD also promotes restfulness, which can give the sufferer from Parkinson’s they need to get the rest they need.

With Parkinson’s and cannabis, both the medical and cannabis communities agree that there is more research that is needed to fully understand, and embrace, the potential for medical marijuana to change the quality of life for those with Parkinson’s Disease.

Interested in Exploring Medical Marijuana for Parkinson’s Disease?

MyCannX is dedicated to being your resource and your connector for exploring whether medical cannabis is an option for your treatment of your Parkinson’s Disease and its symptoms. Your journey starts with a discussion with a qualified doctor who is familiar with how medical marijuana and CBD can interact with your brain and increase the dopamine in your body.

Let us be your guide and help us advocate for more research on Parkinson’s and medical marijuana. Connect with MyCannX to get your cannabis card and begin your journey towards finding out how medical marijuana can treat the motor and non-motor symptoms of Parkinson’s Disease.